004720 Stock Chart & Stats
₩3170.00
-₩5.00(-0.16%)
―
--
Day’s Range― - ―
52-Week Range₩2,590.00 - ₩4,630.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)46.85K
Market Cap
₩71.79B
Enterprise Value₩45.24K
Total Cash (Recent Filing)₩20.05B
Total Debt (Recent Filing)₩698.13M
Price to Earnings (P/E)―
Beta-0.02
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6137.00
Shares Outstanding22,654,366
10 Day Avg. Volume45,747
30 Day Avg. Volume46,848
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.62
Price to Sales (P/S)0.53
P/FCF Ratio23.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
004720 FAQ
What was PharmGen Science, Inc.’s price range in the past 12 months?
PharmGen Science, Inc. lowest stock price was ₩2590.00 and its highest was ₩4630.00 in the past 12 months.
What is PharmGen Science, Inc.’s market cap?
PharmGen Science, Inc.’s market cap is ₩71.79B.
When is PharmGen Science, Inc.’s upcoming earnings report date?
PharmGen Science, Inc.’s upcoming earnings report date is Nov 18, 2026 which is in 89 days.
How were PharmGen Science, Inc.’s earnings last quarter?
PharmGen Science, Inc. released its earnings results on Aug 14, 2026. The company reported -₩614 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is PharmGen Science, Inc. overvalued?
According to Wall Street analysts PharmGen Science, Inc.’s price is currently Undervalued.
Does PharmGen Science, Inc. pay dividends?
PharmGen Science, Inc. does not currently pay dividends.
What is PharmGen Science, Inc.’s EPS estimate?
PharmGen Science, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PharmGen Science, Inc. have?
PharmGen Science, Inc. has 22,654,366 shares outstanding.
What happened to PharmGen Science, Inc.’s price movement after its last earnings report?
PharmGen Science, Inc. reported an EPS of -₩614 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.64%.
Which hedge fund is a major shareholder of PharmGen Science, Inc.?
Currently, no hedge funds are holding shares in KR:004720
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PharmGen Science, Inc.
PharmGen Science, Inc., originally founded in 1961 as Wooridul Pharmaceutical Limited, is a South Korean company primarily involved in the research, development, manufacturing, and distribution of pharmaceutical products. Based in Hwaseong, South Korea, the firm offers a diverse portfolio encompassing prescription medications, over-the-counter drugs, nutritional supplements, and cosmetic items. These are available in various forms, including tablets, hard capsules, granules, ointments, syrups, and suspensions.
Daewoong Co., Ltd.
―
KOREA PHARMA Co., Ltd.
―
Osang Healthcare Co. Ltd.
―
Icure Pharmaceutical Incorporation
―
Enzychem Lifesciences Corp.
―